Thanks to the Ted and Mollie Carr Fund through Perpetual Guardian the Gut Cancer Foundation is calling for applications for:

Part time GI Cancer Clinical Fellowship or Clinical Research

Fellowship

The Gut Cancer Foundation offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year for three years supported by Ted and Mollie Carr through Perpetual Guardian. The Fellowship is for the support of outstanding graduates working in the Auckland region from all relevant health professions, who are able to combine their clinical work with research to improve the quality of life and potential survival for people living with a GI cancer. 

The Fellowship is tenable for a period of up to three years. Applications are open to appropriately qualified individuals with New Zealand residency, permanent residency or citizenship, who hold a relevant degree or are in the process of completing their training.  

The GI Cancer Clinical Fellowship would be available in (but not limited to) the speciality areas of cancer surgery, radiation oncology, medical oncology, palliative care, cancer genetics, radiology, anatomical pathology, nutrition, psychiatry or public health.

The salary will be the equivalent to the appropriate level of remuneration of the applicant’s current employment. Please provide evidence of your current salary per annum. The Foundation will provide a contribution towards working expenses of $5,000 per annum. The Foundation has a total of $45,000 per annum for remuneration of salary costs only.  

 Clinical Research Project

This application can also be in the form of a GI Cancer Clinical Research project to the value of $50,000 (GST excl) annually in the Auckland region. This can be one project annually or for up to three years at a total value of $150,000 (GST excl) paid in annual instalments of $50,000 (GST excl). The criteria for applicants are the same as for the Fellowship including the requirement that the research is conducted in  the Auckland region. 

Application forms are available by emailing info@gutcancer.org. nz. Once completed the forms must be received by GCF NZ by email to info@gutcancer.org.nz by 5 pm, 1st March 2018.

Subject: Call for Applications: Part time 0.3-0.5 FTE Gastro-Intestinal (GI) Cancer Clinical Research Fellowship

Subject title: GICI NZ: Call for Applications – Part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship

The GI Cancer Institute NZ is calling for applications for:

Part time GI Cancer Clinical Fellowship

The GI Cancer Institute NZ offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year supported by the Hugh Green Foundation. The Fellowship is for the support of outstanding graduates from all relevant health professions, who are able to combine their clinical work with research to improve the quality of life and potential survival for people living with a GI cancer.

The Fellowship is tenable for a period of up to two years. Applications are open to appropriately qualified individuals with New Zealand residency, permanent residency or citizenship, who hold a relevant degree or are in the process of completing their training.

The GI Cancer Clinical Fellowship would be available in (but not limited to) the speciality areas of cancer surgery, radiation oncology, medical oncology, palliative care, cancer genetics, radiology, anatomical pathology, nutrition, psychiatry or public health.

All forms: GICI NZ Call for applications for a GI Cancer Clincal Fellowship 2018 GICI Standard CV Template Please provide all details requested by the 1st March 2018. You will be notified of the outcome of an application by the 1st April 2018.

Dr Janet Rhodes is a surgical registrar trainee who has been awarded $50,000, thanks to the Hugh Green Foundation, to take time out of her clinical work to complete her PhD. Her supervisors are Professor John McCall and Dr Roslyn Kemp who are well known to GICI. Her words below describe the importance of her work.

“Colorectal cancer (CRC) is the second highest cause of cancer death in New Zealand. Some patients require surgery alone, while others need chemotherapy to complete treatment. It is not always clear which patients will require chemotherapy to optimise their chance of survival.
The Immunoscore is a recently developed tool that measures the patient’s immune response to cancer and helps to determine which patients may need additional therapies. My PhD will validate the use of the Immunoscore in New Zealand CRC. I will identify other aspects of the Immunoscore to improve its ability to predict outcomes for the patient”.

Congratulations Janet, we look forward to reading your progress.